Status:

COMPLETED

Case-control Study of Sleep Disorders in Children With Cystic Fibrosis

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Cystic Fibrosis

Sleep Disorder

Eligibility:

All Genders

6-17 years

Brief Summary

Our primary purpose is to compare the prevalence of sleep disorders in children aged 6 to 17 with cystic fibrosis versus controls with a Sleep disorder screening score, the SDSC. Our hypothesis is tha...

Eligibility Criteria

Inclusion

  • Inclusion criteria for the case group :
  • Cystic fibrosis followed at the pediatric (Centre de Ressources et de Compétences de la Mucoviscidose) in Strasbourg
  • Aged from 6 to 17 years old
  • Non hospitalized
  • Able to read and understand French language
  • Accompanied by at least one of his parents
  • Inclusion criteria for the control group :
  • Emergency surgical consultation
  • Aged from 6 to 17 years old
  • Non hospitalized
  • Able to read and understand French langage
  • Accompanied by at least one of his parents
  • Exclusion criteria:
  • Children under 6 years old
  • Children over 17 years old
  • Children and parents who don't understand or can't read French language
  • Hospitalized children
  • Children unaccompanied by their parents

Exclusion

    Key Trial Info

    Start Date :

    May 20 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 20 2021

    Estimated Enrollment :

    150 Patients enrolled

    Trial Details

    Trial ID

    NCT04847882

    Start Date

    May 20 2021

    End Date

    December 20 2021

    Last Update

    February 17 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hôpitaux Universitaire de Strasbourg

    Strasbourg, France, 67091